Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127743191 | 12774319 | 1 | I | 20160327 | 20160405 | 20160923 | 20160923 | EXP | BR-ALEXION-A201602602 | ALEXION | 34.39 | YR | F | Y | 61.50000 | KG | 20160923 | CN | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127743191 | 12774319 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, UNK, FOR 4 WEEKS | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||
127743191 | 12774319 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 1200 MG, Q2W FOR 4 WEEKS | 125166 | 1200 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | ||||||
127743191 | 12774319 | 3 | C | PINDOLOL. | PINDOLOL | 1 | Unknown | 10 MG, BID | 0 | 10 | MG | TABLET | BID | ||||||
127743191 | 12774319 | 4 | C | PINDOLOL. | PINDOLOL | 1 | Unknown | 10 MG, TID | 0 | 10 | MG | TABLET | TID | ||||||
127743191 | 12774319 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 10 MG, QD, 1 TAB | 0 | 10 | MG | TABLET | QD | ||||||
127743191 | 12774319 | 6 | C | CLEXANE | ENOXAPARIN SODIUM | 1 | Unknown | 40 MG, UNK | 0 | 40 | MG | ||||||||
127743191 | 12774319 | 7 | C | CLEXANE | ENOXAPARIN SODIUM | 1 | Unknown | 20 UNK, UNK | 0 | 20 | MG | ||||||||
127743191 | 12774319 | 8 | C | ERYTHROPOIETIN | ERYTHROPOIETIN | 1 | Unknown | 4000 IU, TIW | 0 | 4000 | IU | TIW | |||||||
127743191 | 12774319 | 9 | C | CLAVULIN /00756801/ | AMOXICILLINCLAVULANIC ACID | 1 | Unknown | 500 MG, QD, 1 TAB | 0 | 500 | MG | TABLET | QD | ||||||
127743191 | 12774319 | 10 | C | AAS | ASPIRIN | 1 | Unknown | 1 TAB, QD | 0 | TABLET | QD | ||||||||
127743191 | 12774319 | 11 | C | NORIPURUM | IRON POLYMALTOSE | 1 | Unknown | UNK, QW | 0 | /wk |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127743191 | 12774319 | 1 | Haemolytic uraemic syndrome |
127743191 | 12774319 | 3 | Hypertension |
127743191 | 12774319 | 5 | Product used for unknown indication |
127743191 | 12774319 | 6 | Product used for unknown indication |
127743191 | 12774319 | 8 | Product used for unknown indication |
127743191 | 12774319 | 9 | Prophylaxis |
127743191 | 12774319 | 10 | Product used for unknown indication |
127743191 | 12774319 | 11 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127743191 | 12774319 | OT |
127743191 | 12774319 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127743191 | 12774319 | Blood thyroid stimulating hormone abnormal | |
127743191 | 12774319 | Exposure during pregnancy | |
127743191 | 12774319 | Placental insufficiency | |
127743191 | 12774319 | Procedural pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127743191 | 12774319 | 1 | 20150718 | 20150807 | 0 | |
127743191 | 12774319 | 2 | 20150814 | 0 |